| Product Name | MF | CAS | Details |
|---|
| 4-(aminomethyl)piperidin-2-one | C6H12N2O | 1234615-77-0 | Details |
| 1,8-Diaza-2,9-diketocyclotetradecane | C12H22N2O2 | 56403-09-9 | Details |
| 2-Acetamido-3-(1H-imidazol-4-yl)propanamide | C8H12N4O2 | 10467-31-9 | Details |
| 2-bromo-1-(3,3-difluorocyclobutyl)ethan-1-one | C6H7BrF2O | 1619911-80-6 | Details |
| Moclobemide - Bio-X ? | C13H17ClN2O2 | 71320-77-9 | Details |
| 2-Ethyl-2-oxazoline | C5H9NO | 10431-98-8 | Details |
| Melitracen hydrochloride | C21H26ClN | 10563-70-9 | Details |
| Dihydroxyfumaric acid hydrate | C4H4O6 | 199926-38-0 | Details |
| H-NPKASLLSL-OH | Details |
| N-Biphenyl-4-yl-2-isopropylamino-acetamide | C17H20N2O | 852406-44-1 | Details |
| [5-(4-Chlorophenyl)-4-methyl-4H-1,2,4-triazol-3-yl]methanol | C10H10ClN3O | 1126635-66-2 | Details |
| {6-Oxabicyclo[3.2.1]octan-1-yl}methanamine hydrochloride | 2243507-16-4 | Details |
| 1-Cyclopropylpyrrolidin-3-one | C7H11NO | 1096881-62-7 | Details |
| (4-Chloro-6-methylpyrimidin-2-yl)methanol | C6H7ClN2O | 1532612-40-0 | Details |
| Methyl 2-amino-6-chloropyrimidine-4-carboxylate | C6H6ClN3O2 | 6299-83-8 | Details |
| H-VLVLDTDYK-OH | Details |
| 3-Methyl-1-benzothiophene-5-carbonitrile | C10H7NS | 19404-23-0 | Details |
| 1-Benzothiophene-4-carbonitrile | C9H5NS | 17347-34-1 | Details |
| H-GVNDNEEGFFSAR-OH | Details |
| Adenosine-5'-O-diphosphoribose phosphate | C15H24N5O17P3 | 53595-18-9 | Details |
| 6-(1,1-Difluoroethyl)pyridine-3-carboxylic acid | C8H7F2NO2 | 1211515-90-0 | Details |
| Mezagitamab | 2227490-52-8 | Details |
| 1',3',3'-Trimethyl-6-nitro-1',3'-dihydrospiro[chromene-2,2'-indole]-5',8-diol | C19H18N2O5 | 1253909-21-5 | Details |
| 3-(2-Bromophenyl)-1{H}-pyrazole-5-carboxylic acid | C10H7BrN2O2 | 1038915-04-6 | Details |
| (3S,6R)-3-Isopropyl-6-methylcyclohexene | C10H18 | 5113-93-9 | Details |
| C.I.Reactive Orange 2 | C26H20ClN9Na3O11S33* | 6014-69-3 | Details |
| PCNA antibody | Details |
| Methyl 3-hydrazinylbenzoate hydrochloride | C8H11ClN2O2 | 167626-26-8 | Details |
| Collagen Type IV protein | Details |
| 1-tert-Butyl-3-(2,4-difluorophenyl)-1H-pyrazole-4-carboxylic acid | C14H14F2N2O2 | 1152548-23-6 | Details |
| Granzyme A antibody | Details |
| TMB Peroxidase Substrate ELISA | Details |
| 1,3-Dimethyluracil | C6H8N2O2 | 874-14-6 | Details |
| [1,2-Bis(diphenylphosphino)ethane]nickel(II) Dichloride | C26H24Cl2NiP2 | 14647-23-5 | Details |
| 1-(4-Ethylphenyl)-4,4-difluorobutane-1,3-dione | C12H12F2O2 | 832741-19-2 | Details |
| N,N-Dimethyl-4-(pyridin-4-yl)aniline | C13H14N2 | 1137-80-0 | Details |
| 4-Chloro-2-butyn-1-ol | C4H5ClO | 13280-07-4 | Details |
| 5-Methoxycarbonyl-2,3-dihydro-1H-indole hydrochloride | C10H12ClNO2 | 1187928-10-4 | Details |
| Bis(2-methylphenyl)methanamine | C15H17N | 246853-44-1 | Details |
| RNF4 protein (His tag) | Details |
| 1-(4-tert-Butylphenyl)-4-amino-4,5,6,7-tetrahydroindazole | C17H23N3 | 1203661-49-7 | Details |
| 5-[(2-Chloro-4,6-dimethylphenyl)amino]-1,3,4-thiadiazole-2-thiol | C10H10ClN3S2 | 873810-47-0 | Details |
| BMS 777607 | C25H19ClF2N4O4 | 1025720-94-8 | Details |
| 1-(Pyrrolidin-1-ylcarbonyl)piperazine hydrochloride | C9H18ClN3O | 1172232-02-8 | Details |
| C1orf83 Blocking Peptide | Details |
| 1-(2-Azido-1,1-difluoroethyl)-4-chlorobenzene | C8H6ClF2N3 | 1254038-57-7 | Details |
| Ethyl N-(1-amino-4-methylpentan-2-yl)carbamate | C9H20N2O2 | 1087792-22-0 | Details |
| 4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)butanoic acid | C10H19BO4 | 2286357-15-9 | Details |
| Tricin 7-o-glucoside | C23H24O12 | 32769-01-0 | Details |
| 3-(3-Methylbutyl)-2-sulfanyl-3,4-dihydroquinazolin-4-one | C13H16N2OS | 431931-55-4 | Details |
| SPTLC1 Blocking Peptide | Details |
| Oxybutynin EP impurity A | C22H35NO3 | 1199574-71-4 | Details |
| 4-Methyl-1-(trifluoroacetyl)piperidine-4-carbonitrile | C9H11F3N2O | 1443980-84-4 | Details |
| CENPH antibody | Details |
| 5-(Pyrazin-2-yl)pyridine-2-carboxylic acid | C10H7N3O2 | 1340504-76-8 | Details |
| (1,2,5-Trimethyl-1H-pyrrol-3-yl)methanamine hydrochloride | C8H15ClN2 | 1820673-29-7 | Details |
| Ondansetron impurity G | C17H17N3O | 99614-03-6 | Details |
| 6-(Ethoxycarbonyl)-2-hydroxypyridine-3-carboxylic acid | C9H9NO5 | 87762-51-4 | Details |
| ethyl 3-((N-((phenylamino)carbonylamino)carbamoyl)methoxy)benzoate | C18H19N3O5 | 1024440-28-5 | Details |
| 7-Bromo-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride | C10H13BrClN | 2287316-81-6 | Details |
| 14-Dehydrobrowniine | C25H39NO7 | 4829-56-5 | Details |
| 3-(4-Fluorophenyl)cyclobutan-1-amine hydrochloride | C10H13ClFN | 1269152-30-8 | Details |
| [5-Bromo-2-(morpholin-4-yl)pyridin-3-yl]methanol | C10H13BrN2O2 | 1247213-10-0 | Details |
| NOX2/gp91phox Antibody | Details |
| tert-Butyl 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-oxane]-5-carboxylate | C15H23N3O3 | 1955557-23-9 | Details |
| Sodium 3-(piperazin-2-yl)propanoate | C7H15N2NaO2 | 1796902-11-8 | Details |
| 2-(2,2-dimethylpropanoyl)-3-(phenylamino)-3-sulfanylprop-2-enenitrile | C14H16N2OS | 1025530-23-7 | Details |
| R-(-)-3-Quinuclidinyl chloroformate | C8H12ClNO2 | 201660-37-9 | Details |
| Actinomycin V | C62H84N12O17 | 18865-48-0 | Details |
| Methyl 4-(1-aminoethyl)piperidine-1-carboxylate hydrochloride | C9H19ClN2O2 | 1803610-51-6 | Details |
| Ethyl 2-(3-amino-1H-pyrazol-1-yl)pentanoate | C10H17N3O2 | 1555580-28-3 | Details |
| 2-[(4-Methoxyphenyl)methyl]-5-methyl-2,3-dihydro-1H-pyrazol-3-imine hydrochloride | C12H16ClN3O | 1355602-25-3 | Details |
| CD72.1 antibody (PE) | Details |
| OR2K2 Blocking Peptide | Details |
| H-ITGLDPAGPNFEYAEAPSR^-OH | Details |
| 1,7,7-Trimethyl-1H,4H,5H,6H,7H,8H-pyrazolo[4,3-c]azepine | C10H17N3 | 2059993-44-9 | Details |
| 3-[(Adamantan-1-yl)amino]propanenitrile | C13H20N2 | 32901-14-7 | Details |
| LCBiot-EDQVDPRLIDGK-OH | Details |
| 1-[(tert-Butoxy)carbonyl]-6-methoxy-1H,2H,3H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | C14H18N2O5 | 2225146-25-6 | Details |
| 3-(2-Phenylethyl)-2-sulfanyl-5-(thiophen-2-yl)-3H,4H-thieno[2,3-d]pyrimidin-4-one | C18H14N2OS3 | 731820-91-0 | Details |
| 1-(Difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carbaldehyde | C7H5F2NO2 | 1263178-10-4 | Details |
| rnhA protein (His tag) | Details |
| Human Kappa Light Chain | Details |
| 2-(3-Chlorophenyl)-2H,4H,6H-thieno[3,4-c]pyrazol-3-amine | C11H10ClN3S | 214542-51-5 | Details |
| 1-(tert-Butylsulfamoyl)cyclobutane-1-carboxylic acid | C9H17NO4S | 2167013-26-3 | Details |
| Anti-Dixin antibody R1G - 2mg/mL | Details |
| GABRG2 antibody | Details |
| 4-Amino-N-(5-ethyl-[1,3,4]thiadiazol-2-yl)-benzenesulfonamide | C10H12N4O2S2 | 94-19-9 | Details |
| BRF2 Blocking Peptide | Details |
| tert-Butyl 2-(Iodomethyl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate | C13H22INO3 | 1160246-84-3 | Details |
| a-Chaconine | C45H73NO14 | 20562-03-2 | Details |
| 1-Benzyl-N-(pyridin-4-ylmethyl)piperidin-3-amine | C18H23N3 | 1097054-27-7 | Details |
| Methyl 2-{[(furan-2-yl)methyl]amino}acetate | C8H11NO3 | 1019577-40-2 | Details |
| 4-Chloro-3,5-dihydroxybenzoic acid | C7H5ClO4 | 102338-87-4 | Details |
| entB Antibody | Details |
| 1-Benzyl-5-methoxy-2-methyl-1H-indole-3-carboxylic acid | C18H17NO3 | 132105-71-6 | Details |
| (2S)-4-Methylpentan-2-amine hydrochloride | 1137082-59-7 | Details |
| 3-Amino-1-cyclopentyl-1H-pyrazole-4-carboxylic acid | C9H13N3O2 | 1795473-91-4 | Details |
| 2-[2-(Dimethylamino)ethoxy]benzoic acid hydrochloride | C11H16ClNO3 | 1177320-86-3 | Details |
| Cryptomerin B | C32H22O10 | 22012-98-2 | Details |
| Product Total： Product Page： | ||||
| 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 | ||||